SGRY
Surgery Partners·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural
Analyst consensus is mixed: 40% Strong Buy, 40% Buy, 20% Neutral, yielding a weighted rating of 3.83/10 and a pessimistic market view as price fell 7.26%. Fund‑flow patterns are generally positive for medium and large investors, offset by overall negative inflow trends.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
40%
Buy
40%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-05
InstitutionUBS
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for SGRY?
- SGRY holds a Bearish analyst rating, with 40% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.75/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
